Harvard Bioscience (HBIO) - Year-over-year earnings per share growth for the last twelve months
Harvard Bioscience is implementing ESG principles by increasing instrument durability and recycling plastic. Quarterly net income per share dynamics demonstrate a reversal driven by the release of high-margin dispensing systems and the low demand elasticity for unique electroporation technologies. The current -108.00 metric determines the profitability parameter status, capturing the company's final yield trend.
HBIO (Harvard Bioscience Inc.): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Harvard Bioscience|HBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Harvard Bioscience|HBIO - Company Total Debt|Debts to Book Capitalization Harvard Bioscience|HBIO - Long-Term Debt|Company Short-Term Debt Harvard Bioscience|Quick Liquidity Indicator harvardbioscience.com
- earnings and valuation multiples information:
HBIO - Profit After Payment of Taxes|Expected Profit Harvard Bioscience|HBIO - Business Payback Period|Forward P/E Multiple Harvard Bioscience, Inc.|HBIO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Harvard Bioscience|HBIO - Operating profit EBITDA|Earnings per share for the last twelve months Harvard Bioscience|HBIO - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months harvardbioscience.com|HBIO - Earnings per share growth in current year|Earnings growth forecast for next year Harvard Bioscience
Basic company analysis:Harvard Bioscience, Inc. - HBIO
Harvard Bioscience's stable position in the laboratory equipment segment and high customer switching costs create a foundation for predictable cash flow. By analyzing the quarterly EPS growth index, an investor assesses the growth rate of net income per share, which allows for determining the efficiency of monetizing market demand and avoiding overpaying for the asset during periods of temporary economic acceleration.
Analysis of competing companies
Intuitive (ISRG) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months DHR|Year-over-year earnings per share growth for the last twelve months Becton, Dickinson and Company|STERIS Group (STE) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months WST (West Pharmaceutical Services)|Year-over-year earnings per share growth rate for the last twelve months BAX|Year-over-year earnings per share growth for the last twelve months Masimo MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX: Year-over-year net earnings per share growth for the last 12 months|MMSI - Quarterly EPS earnings growth|Envista Holdings (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months icumed.com|XRAY (Dentsply Sirona) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Vascular Inc LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure Corp (ATRC)|STAAR Surgical Co - Year-over-year earnings per share growth for the last 12 months|Chromadex Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ZIMV (zimvie.com)|ANGO - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Cerus Corp. CERS|TKNO: Quarterly EPS earnings growth|Monogram Orthopedics Inc. - Year-over-year earnings per one share growth for the last 12 months|STSS (Sharps Technology Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth InfuSystem Inc|Year-over-year earnings per share growth for the last twelve months Utah Medical Products, Inc. (UTMD)|KRMD (korumedical.com) - Year-over-year earnings per one share growth for the last 12 months|Nyxoah, S.A. - Year-over-year net earnings per share growth for the last 12 months|Microbot Medical, Inc - Year-over-year earnings per share growth for the last twelve months|Pro-Dex, Inc. - Quarterly EPS earnings growth|ZTEK - Quarterly EPS earnings growth|Elutia (ELUT) - Year-over-year earnings per share growth for the last twelve months|Milestone Scientific Inc - Year-over-year earnings per one share growth for the last 12 months|NXGL (NEXGEL, Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RVP (Retractable Tech)|Year-over-year net earnings per share growth for the last 12 months FEMY (Femasys Inc.)|MHUA (meihuamed.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth POAI (Predictive Oncology Inc.)|Callan JMB Inc. - Year-over-year earnings per share growth for the last twelve months|Atrion Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NeuroMetrix Corporation NURO
